Pfizer sees $10 billion-$15 billion in annual mRNA vaccine revenue by 2030
1 year ago
No Comments
Related Posts
European shares set to snap winning streak on slowdown fears, weak earnings
January 19, 2023
Coca Cola Stock Gains 2% on Earnings Beat, Results Seen as 'Much Better Than Expected'
April 25, 2022
Lufthansa cancels 30 flights to Russia this week
February 28, 2022
Zscaler Shares Gain After 'Very Good' Results
May 27, 2022
T-Mobile Gains on $14 Billion Stock Buyback Plan, Seen as a 'Significant Positive'
September 9, 2022
S&P 500 Slips as Rising U.S. Yields Dent Growth Stocks
August 22, 2022
About The Author
